Abdu Zakir, Belayneh Wondwossen, Dule Aman, Alemu Solomon Seyife, Wedajo Lema Fikadu, Hajure Mohammedamin, Tesfaye Gebremeskel Mulatu, Workneh Yadeta Alemayehu, Gezimu Wubishet, Adem Hussen Mustefa, Tefera Bilisumamulifna, Habib Sadik
Department of Psychiatry, Nursing, Midwifery, and Public Health, College of Health Sciences, Mattu University, Mattu, Ethiopia.
Department of Medicine, Gambella General Hospital, Gambella, Ethiopia.
Front Psychiatry. 2025 Jan 29;16:1507020. doi: 10.3389/fpsyt.2025.1507020. eCollection 2025.
Among various mental disorders, anxiety disorder is commonly reported in HIV-positive individuals. Compared to the general population, people living with HIV/AIDS exhibit a higher prevalence of anxiety, with an estimated figure of 68.2% 29% in the general population. However, there is a scarcity of studies on the prevalence and associated factors of anxiety among people living with HIV/AIDS in Ethiopia.
An institution-based cross-sectional study was conducted among 320 participants at Gambella General Hospital. The Beck Anxiety Inventory (BAI) scale, Fagerström Test for Nicotine Dependence (FTND), Severity of Dependence Scale (SDS), and the Alcohol Use Disorder Identification Test (AUDIT) were used to collect the data. Data analysis was performed using SPSS version 25. Bivariate and multivariable logistic regressions were employed to identify independently associated variables, and statistical significance was determined at a -value <0.05.
Out of a total of 323 samples, 320 respondents completed all items, resulting in a response rate of 99.07%. The results showed that 28.4% (95% CI = 23.2-33.9) of participants had anxiety. Factors such as being aged 25 to 40 years, having seen a counselor, HIV disclosure, alcohol use disorders, and perceived high stigma were significantly associated with anxiety in people living with HIV (PLWH).
In the study area, about two out of every seven people living with HIV/AIDS experienced anxiety symptoms. Factors such as being aged 25 to 40 years, having seen a counselor, HIV disclosure, alcohol use disorders, and perceived high stigma were significantly associated with anxiety in this population. Based on these findings, timely intervention is recommended to enhance the overall well-being and quality of life for people living with HIV (PLWH), leading to better health outcomes, reducing the burden of mental health issues, and supporting more holistic, patient-centered care.
在各种精神障碍中,焦虑症在艾滋病毒呈阳性的个体中普遍存在。与普通人群相比,艾滋病毒/艾滋病感染者的焦虑患病率更高,普通人群的估计患病率为29%,而艾滋病毒/艾滋病感染者的这一比例为68.2%。然而,埃塞俄比亚关于艾滋病毒/艾滋病感染者焦虑症患病率及相关因素的研究较少。
在甘贝拉综合医院对320名参与者进行了一项基于机构的横断面研究。使用贝克焦虑量表(BAI)、尼古丁依赖弗格斯特罗姆测试(FTND)、依赖严重程度量表(SDS)和酒精使用障碍识别测试(AUDIT)收集数据。使用SPSS 25版进行数据分析。采用双变量和多变量逻辑回归来确定独立相关变量,以P值<0.05确定统计学显著性。
在总共323个样本中,320名受访者完成了所有项目,回复率为99.07%。结果显示,28.4%(95%置信区间=23.2-33.9)的参与者患有焦虑症。年龄在25至40岁、咨询过顾问、披露艾滋病毒感染情况、酒精使用障碍以及感知到高度耻辱感等因素与艾滋病毒感染者(PLWH)的焦虑症显著相关。
在研究区域,每七名艾滋病毒/艾滋病感染者中约有两人出现焦虑症状。年龄在25至40岁、咨询过顾问、披露艾滋病毒感染情况、酒精使用障碍以及感知到高度耻辱感等因素与该人群的焦虑症显著相关。基于这些发现,建议及时进行干预,以提高艾滋病毒感染者(PLWH)的整体幸福感和生活质量,带来更好的健康结果,减轻心理健康问题的负担,并支持更全面、以患者为中心的护理。